Saad Mark E 4
4 · Axsome Therapeutics, Inc. · Filed Jun 6, 2023
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-02+5,681→ 5,681 totalExercise: $74.12From: 2024-06-02Exp: 2033-06-02→ Common Stock (5,681 underlying)
Footnotes (1)
- [F1]The option vests in full on the one-year anniversary of the date of grant, June 2, 2024.